Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Myelomonocytic, Acute 2Leukemia, Myeloid, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia 2

Interventions

Cytarabine 10Idarubicin 5Daunorubicin 5Peripheral Blood Stem Cell Transplantation 4Mitoxantrone 4Etoposide 4Radiotherapy 3Filgrastim 3Cyclophosphamide 3lintuzumab 2Microarray Analysis 2Busulfan 2sargramostim 1midostaurin 1laromustine 1eltrombopag 1dexamethasone acetate 1aldesleukin 1Tretinoin 1Thioguanine 1Sorafenib 1Reverse Transcriptase Polymerase Chain Reaction 1Polymerase Chain Reaction 1Mesna 1Granulocyte Colony-Stimulating Factor 1Genetic Testing 1Gene Expression Profiling 1Gemtuzumab 1Everolimus 1DNA Methylation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Leukemia, Monocytic, Acute × lintuzumab × Clear all
NCT00006084 2013-12-19

Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia

National Cancer Institute (NCI)

Phase 2 Unknown
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT00006045 2013-11-06

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡